Skip to main content
. Author manuscript; available in PMC: 2024 Dec 2.
Published in final edited form as: Curr Rheumatol Rep. 2019 Nov 21;21(11):64. doi: 10.1007/s11926-019-0864-3

Fig. 1.

Fig. 1

A 49-year-old woman presented with the characteristic Gottron sign and heliotrope rash. She reported progressive muscle weakness during the last 2 months. Blind screening with [18F]-FDG PET/CT (left panel) disclosed a uterine mass yielding a high standardized uptake value (SUV max = 12.8) (arrow). Hysterectomy revealed an undifferentiated uterine sarcoma. The right panel shows [18F]-FDG PET image